Role of pyroptosis in COVID-19

Author:

Çelik Mehmet1ORCID,Ceylan Mehmet Reşat1ORCID,Karahan Mahmut Alp2ORCID,Koyuncu İsmail3ORCID,Dinçer Nevin Güler4ORCID,Alkan Sevil5ORCID

Affiliation:

1. Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, University of Harran, Şanlıurfa, Turkey

2. Department of Anesthesiology, Faculty of Medicine, University of Harran, Şanlıurfa, Turkey

3. Department of Medical Biochemistry, Faculty of Medicine, University of Harran, Şanlıurfa, Turkey

4. Department of Statistics, Faculty of Science, University of Muğla Sıtkı Koçman, Muğla, Turkey

5. Department of Infectious Diseases, Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale, Turkey

Abstract

<b>Aim:</b> In this study, we aimed to investigate the relationship between gasdermin-D, caspase-1, IL-1β and NLRP3, biomarkers that play an important role in COVID-19, and pyroptosis.<br /> <b>Material and Methods:</b> This study was carried out with 58 participants, 28 (48.28%) of whom were diagnosis with COVID-19, and 30 (51.72%) of whom were healthy volunteers (control group).<br /> <b>Results:</b> There were no statistically significant differences between the gasdermin-D, caspase-1, IL-1β, and NLRP3 levels as a result of all statistical comparisons performed. However, IL-1β values both during the discharge period and during the hospitalization period were considerably higher than those of the control group. At the discharge period, IL-1β values of the patients with severe COVID-19 category had higher than moderate patients, and the patients with moderate than the patients with mild patients.<br /> <b>Conclusion</b>: It was observed that IL-1β, which is one of the cytokines released as a result of cell death in the pyroptosis mechanism, was higher in the COVID-19 patients in both the hospitalization and discharge periods compared to the control group. Although not statistically significant these results could support the relationship between pyroptosis and COVID-19.

Publisher

JSC National Scientific Medical Research Center

Subject

General Medicine

Reference48 articles.

1. Rabi FA, Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS-CoV-2 and coronavirus disease 2019: What we know so far. Pathogens. 2020;9:231. https://doi.org/10.3390/pathogens9030231

2. Republic of Turkey Ministry of Health, General Directorate of Public Health. COVID-19 (SARS-CoV-2 infection) general information, epidemiology and diagnosis. https://covid19.saglik.gov.tr/TR-66337/genel-bilgiler-epidemiyoloji-ve-tani.html. [Accessed 10 May 2022].

3. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020: World Health Organization; 2020. Available: https://www. who. int/ dg/ speeches/ detail/ who- director- general- s- openingremarks- at- the- media- briefing- on- covid- 19- 11- march- 2020 [Accessed 9 Apr 2020].

4. WHO Coronavirus (COVID-19) Dashboard. Available: https://covid19.who.int/ [Accessed 10 May 2022].

5. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus Infected Pneumonia. N Engl J Med. 2020;382:1199. https://doi:10.1056/NEJMoa2001316

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3